Vertex Pharmaceuticals Incorporated (VRTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 492.26 |
| Open | 493.14 |
| Bid | 495.22 x 100 |
| Ask | 495.66 x 100 |
| Day's range | 492.17 - 502.97 |
| 52-week range | 340.20 - 503.99 |
| Volume | |
| Avg. volume | 1,188,129 |
| Market cap | 127.803B |
| Beta (5Y monthly) | 0.39 |
| PE ratio (TTM) | 32.14 |
| EPS (TTM) | 15.41 |
| Earnings date | 01 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 481.41 |
ZacksTwist Bioscience (TWST) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Twist Bioscience (TWST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GuruFocus.comInsider Sale at Vertex Pharmaceuticals Inc (VRTX) by EVP and CMO Carmen Bozic
Following this sale, the insider now owns 25,539 shares of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc, headquartered in Boston, Massachusetts, is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. Over the past year, Carmen Bozic has sold a total of 45,305 shares of Vertex Pharmaceuticals Inc and has not made any purchases of the stock.
GuruFocus.comBaillie Gifford's Strategic Moves in Q2 2024: A Closer Look at NVIDIA Corp's Impact
Insight into Baillie Gifford (Trades, Portfolio)'s Latest 13F Filings and Portfolio Adjustments
© 2024 Yahoo. All rights reserved.